Взаимосвязь между течением COVID-19 и уровнем половых гормонов у мужчин

Автор: Антонов А.Г., Гамылин К.И., Величко Д.Н., Гордеев В.В.

Журнал: Экспериментальная и клиническая урология @ecuro

Рубрика: Андрология

Статья в выпуске: 2 т.17, 2024 года.

Бесплатный доступ

Введение. COVID-19 на сегодняшний день остается актуальной проблемой в сфере здравоохранения. Новый мутагенный штамм, как и его предшественники, также вызывает полисистемное повреждение организма. Актуальным вопросом в изучении патогенных свойств возбудителя является влияние вируса на изменение уровня половых гормонов у мужчин.

Covid-19, sars-cov-2, новая коронавирусная инфекция, мужская фертильность, гипогонадизм, трансмембранная сериновая протеаза 2, активные формы кислорода, половые гормоны

Короткий адрес: https://sciup.org/142242607

IDR: 142242607   |   DOI: 10.29188/2222-8543-2024-17-2-52-57

Список литературы Взаимосвязь между течением COVID-19 и уровнем половых гормонов у мужчин

  • Alexander B. Collins, Lei Zhao, Ziwen Zhu, Nathan T. Givens, Qian Bai, Mark R. Wakefield, Yuijiang Fang. Impact of COVID-19 on Male Fertility. Urology 2022;164:33-39. https://doi.Org/10.1016/j.urology.2021.12.025.
  • Yassin A, Shabsigh R, Al-Zoubi RM, Aboumarzouk OM, Alwani M, Nettleship J, Kelly D. Testosterone and Covid-19: An update. Rev Med Virol 2023;33(1):e2395. https://doi.org/10.1002/ rmv.2395.
  • Scully EP, Haverfield J, Ursin RL, Tannenbaum C, Klein SL. Considering how biological sex impacts immune responses and COVID 19 outcomes. Nat Rev Immunol 2020;20(7):442-7. https://doi.org/10.1038/s4157702003488.
  • Auerbach JM, Khera M.Testosterone's Role in COVID-19. J Sex Med 2021;18(5):843-8. https://doi.org/10.1016/j.jsxm.2021.03.004.
  • Tukiainen T, Villani AC, Yen A, Rivas MA, Marshall JL, Satija R, et al. Landscape of X chromosome inactivation across human tissues. Nature 2017;550(7675):244-8. https://doi.org/10.1038/ nature24265.
  • Gebhard C, Regitz-Zagrosek V, Neuhauser HK, Morgan R, Klein SL. Impact of sex and gender on COVID-19 outcomes in Europe. Biol Sex Differ 2020;11(1):29. https://doi.org/10.1186/ s13293-020-00304-9.
  • Li Q, Guan X, Wu P, Wang X, Zhou L, Tong Y, et al. Early transmission dynamics in Wuhan, China, of Novel Coronavirus-infected pneumonia. N Engl J Med 2020;382(13):1199-207. http://dx.doi.org/10.1056/nejmoa2001316.
  • Jin JM, Bai P, He W, Wu F, Liu XF, Han DM, et al. Gender differences in patients with COVID-19: Focus on severity and mortality. Front Public Health 2020;8:152. https://doi.org/10.3389/fpubh.2020.0015.
  • Zhou Y, Chi J, Lv W, Wang Y. Obesity and diabetes as high-risk factors for severe coronavirus disease 2019 (Covid-19). Diabetes Metab Res Rev 2021;37(2):e3377. https://doi.org/10.1002/ dmrr.3377.
  • Wambier C G, Goren A, Vano-Galvan S, Ramos PM, Ossimetha A, Nau G, et al. Androgen sensitivity gateway to COVID-19 disease severity. Drug Dev Res 2020;81(7):771-6. https://doi.org/10.1002/ddr.21688.
  • Montopoli M, Zumerle S, Vettor R, Rugge M, Zorzi M, Catapano CV, et al. Androgen-de-privation therapies for prostate cancer and risk of infection by SARS-CoV-2: a population-based study (N = 4532). Ann Oncol 2020;31(8):1040-5. https://doi.org/10.1016/j.annonc.2020.04.479.
  • Keilich SR, Bartley JM, Haynes L. Diminished immune responses with aging predispose older adults to common and uncommon influenza complications. Cell Immunol 2019;345. https://doi.org/10.1016/jxellimm.2019.103992.
  • Wang X, Huang L, Jiang S, Cheng K, Wang D, Luo Q, et al. Testosterone attenuates pulmonary epithelial inflammation in male rats of COPD model through preventing NRF1-Derived NF-Kb Signaling. J Mol Cell Biol 2021;13(2):128-40. https://doi.org/10.1093/jmcb/mjaa079.
  • Bianchi VE. The Anti-inflammatory effects of testosterone. J Endocr Soc 2019;3(1):91-107. https://doi.org/10.1210/js.2018-00186.
  • Papadopoulos V, Li L, Samplaski M. Why Does COVID-19 kill more elderly men than women? Is there a role for testosterone? Andrology 2020;22(2):129-40. https://doi.org/10.1080/13685538.2018.1482487.
  • Dhindsa S, Champion C, Deol E. Association ofmale hypogonadism with risk of hospitalization for COVID-19. JAMA 2022;5(9):e2229747. https://doi.org/10.1001/jamanetworkopen.2022.29747.
  • Rastrelli G, Di Stasi V, Inglese F, Beccaria M, Garuti M., Di Costanzo D, et al. Low testosterone levels predict clinical adverse outcomes in SARS-CoV-2 pneumonia patients. Andrology 2020;9(1):88-98. https://doi.org/10.1111/andr.12821.
  • Moreno-Perez O, Merino E, Alfayate R, Torregrosa ME, Andres M, Leon-Ramirez JM, et al. Male pituitary-gonadal axis dysfunction in post-acute COVID-19 syndrome. Prevalence and associated factors: a mediterranean case series. Clin Endocrinol 2022;96(3):353-62. https://doi.org/10.1111/cen.14537.
  • Salonia A, Pontillo M, Capogrosso P, Gregori S, Tassara M, Boeri L, et al. Severely low testosterone in males with COVID-19: A case-control study. Andrology 2021;9(4):1043-52. https://doi.org/10.1111/andr.12993.
  • ^ayan S, Uguz M, Saylam B, Akbay E. Effect of serum total testosterone and its relationship with other laboratory parameters on the prognosis of coronavirus disease 2019 (COVID-19) in SARS-CoV-2 infected male patients: a cohort study. Aging Male 2020;23(5):1493-503. https://doi.org/10.1080/13685538.2020.1807930.
  • Ma L, Xie W, Li D, Shi L, Ye G, Mao Y, et al. Evaluation of sex-related hormones and semen characteristics in reproductive-aged male COVID-19 patients. J Med Virol 2021;93(1):456-62. https://doi.org/10.1002/jmv.26259.
  • Pozzilli P, Lenzi A. Commentary: testosterone, a key hormone in the context of COVID-19 pandemic. Metabolism 2020:108:154252. https://doi.org/10.1016/j.metabol.2020.154252.
  • Temiz MZ, Dincer MM, Hacibey I, Yazar RO, Celik C, Kucuk SH, et al. Investigation of SARS-CoV-2 in semen samples and the effects of COVID-19 on male sexual health by using semen analysis and serum male hormone profile: A cross-sectional, pilot study. Andrologia 2021;53(2):e13912. https://doi.org/10.1111/and.13912.
  • Pascual-Goñi E, Fortea J, Martínez-Domeño A, Rabella N, Tecame M, Gómez-Oliva C, et al. COVlD-19-associated ophthalmoparesis and hypothalamic involvement. Neurol Neuroim-munol Neuroinflamm 2020;7(5):e823. https://doi.org/10.1212/NXl.0000000000000823.
  • Xu H, Wang Z, Feng C, Yu W, Chen Y, Zeng X, Liu C. Effects of SARS-CoV-2 infection on male sex-related hormones in recovering patients. Andrology 2021;9(1):107-14. https://doi.org/10.1111/andr.12942.
  • Gökalp Özkorkmaz E, Özdemir Bajaran S, Afjin M, Ajir F. Comparison of testosterone, FSH, LH and E2 hormone levels in infertility suspected males with COVID-19 infection. Medicine (Baltimore) 2023;102(43):e35256. https://doi.org/10.1097/MD.0000000000035256.
  • Kadihasanoglu M, Aktas S, Yardimci E, Aral H, Kadioglu A. SARS-CoV-2 pneumonia affects male reproductive hormone levels: a prospective, cohort study. J Sex Med 2021;18(2):256-64. https://doi.org/10.1016/j.jsxm.2020.11.007.
  • Freeman ME, Kanyicska B, Lerant A, Nagy G. Prolactin: structure, function, and regulation of secretion. Physiol Rev 2000;80(4):1523-631. https://doi.org/10.1152/physrev.2000.80.4.1523.
  • Song E, Bartley CM, Chow RD, Ngo TT, Jiang R, Zamecnik CR, et al. Divergent and self-reactive immune responses in the CNS of COVID-19 patients with neurological symptoms. Cell Rep Med 2021;2(5):100288. https://doi.org/10.1016/j.xcrm.2021.100288.
  • Jara LJ, López-Zamora B, Ordoñez-González l, Galaviz-Sánchez MF, Gutierrez-Melgarejo CI, Saavedra MÁ, et al. The immune-neuroendocrine system in COVID-19, advanced age and rheumatic diseases. Autoimmun Rev 2021;20(11):102946. https://doi.org/10.1016/j.autrev.2021.102946.
  • Al-Kuraishy HM, Al-Gareeb AI, Butnariu M, Batiha GE. The crucial role of prolactin-lac-togenic hormone in Covid-19. Mol Cell Biochem 2022;477(5):1381-92. https://doi.org/10.1007/s11010-022-04381-9.
  • Flores-Espinosa P, Preciado-Martínez E, Mejía-Salvador A, Sedano-González G, Bermejo-Martínez L, Parra-Covarruvias A, et al. Selective immuno-modulatory effect of prolactin upon pro-inflammatory response in human fetal membranes. J Reprod Immunol 2017;123:58-64. https://doi.org/10.1016/j.jri.2017.09.004.
  • Di Rosa M, Zambito AM, Marsullo AR, Li Volti G, Malaguarnera L. Prolactin induces chi-totriosidase expression in human macrophages through PTK, P13-K, and MAPK pathways. J Cell Biochem 2009;107(5):881-9. https://doi.org/10.1002/jcb.22186.
  • Somasundaram NP, Ranathunga 1, Ratnasamy V, Wijewickrama PSA, Dissanayake HA, Yo-gendranathan N, et al. The impact of SARS-Cov-2 virus infection on the endocrine system. J Endocr Soc 2020;4(8):bvaa082. https://doi.org/10.1210/jendso/bvaa082.
  • Zhou Y, Fu B, Zheng X, Wang D, Zhao C, Qi Y et al. Pathogenic T-cells and inflammatory monocytes incite inflammatory storms in severe COVID-19 patients. Natl Sci Rev 2020;7(6):998-1002. https://doi.org/10.1093/nsr/nwaa041.
  • Del Vecchio Filipin M, Brazao V, Santello FH, da Costa CMB, Paula Alonso Toldo M, Rossetto de Morais F, do Prado Júnior JC. Does Prolactin treatment trigger imunoendocrine alterations during experimental T. cruzi infection? Cytokine 2019;121:154736. https://doi.org/10.1016/jxyto.2019.154736.
  • Sen A. Repurposing prolactin as a promising immunomodulator for the treatment of COVID-19: are common antiemetics the wonder drug to fight coronavirus? Med Hypotheses 2020:144:110208. https://doi.org/10.1016/j.mehy.2020.110208.
  • Viveiros A, Rasmuson J, Vu J, Mulvagh SL, Yip CYY, Norris CM, et al. Sex differences in COVID-19: candidate pathways, genetics of ACE2, and sex hormones. Am J Physiol Heart Circ Physiol 2021;320:H296-H304. https://doi.org/10.1152/ajpheart.00755.2020.
  • Aksoyalp Z, Samur D. Sex-related susceptibility in coronavirus disease 2019 (COVID-19): Proposed mechanisms. Eur J Pharmacol 2021;912:17548. https://doi.org/10.1016/j.ejphar.2021.17548.
  • Heil F, Hemmi H, Hochrein H, Ampenberger F, Kirschning C, Akira S, et al. Species-specific recognition of single-stranded RNA via toll-like receptor 7 and 8. Science 2004;303(5633):1526-9. https://doi.org/10.1126/science.1093620.
  • Berghöfer B, Frommer T, Haley G, Fink L, Bein G, Hackstein H. TLR7 ligands induce higher IFN-alpha production in females. J Immunol 2006;177(4):2088-96. https://doi.org/10.4049/ jimmunol.177.4.2088.
  • Mauvais-Jarvis F, Klein SL, Levin ER. Estradiol, Progesterone, 1mmunomodulation, and COVID-19 Outcomes. Endocrinology 2020;161:bqaa127. https://doi.org/10.1210/endocr/ bqaa127.
  • Channappanavar R, Fett C, Mack M, Ten Eyck PP, Meyerholz DK, Perlman S. Sex-based differences in susceptibility to severe acute respiratory syndrome coronavirus infection. J Immunol 2017;198:4046-53. https://doi.org/10.4049/jimmunol.1601896.
Еще
Статья обзорная